Latest News and Press Releases

CARLSBAD, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced that it has completed the sale of an additional...

Des Moines, May 09, 2025 (GLOBE NEWSWIRE) -- In This Article, You'll Discover: Why millions of drivers struggle with fuel efficiency despite modern vehicle advancementsThe real economic and...

GRAND JUNCTION, Colo., May 09, 2025 (GLOBE NEWSWIRE) -- (OTCQB: MAPPF) (TSXV: MAPS) (FSE: 5D00) ProStar Holdings Inc. (the "Company" or "ProStar®") a world leader in Precision Mapping Solutions®, is...

VILNIUS, Lithuania, May 09, 2025 (GLOBE NEWSWIRE) -- The XRP ecosystem is experiencing a major breakthrough as whales and savvy investors flood into the XpFinance ($XPF) token presale, raising...

GLASGOW, Scotland, May 09, 2025 (GLOBE NEWSWIRE) -- In recent years, the search for ways to slow down aging and boost energy has led scientists and wellness seekers alike to a breakthrough compound:...

Dublin, May 09, 2025 (GLOBE NEWSWIRE) -- The "Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2020-2025" report has been added to ResearchAndMarkets.com's offering. The...

Dublin, May 09, 2025 (GLOBE NEWSWIRE) -- The "Hospital Care Collaboration and Licensing Deals 2016-2025" report has been added to ResearchAndMarkets.com's offering.Hospital Care Collaboration and...

SINGAPORE, May 09, 2025 (GLOBE NEWSWIRE) -- With Bitcoin breaking past the $100,000 milestone and Ethereum surging over 20% in just 24 hours, many analysts agree that a new crypto bull market...

Conference Call and Webcast Today at 8:30 a.m. ET OCU400 Phase 3 clinical trial for retinitis pigmentosa (RP) is progressing well and on target for potential BLA/MAA filings by mid-2026Anticipate...

-  This RMAT designation is based on data from 3 clinical studies demonstrating the potential benefit of AAV-GAD as a one-time treatment for Parkinson’s disease -  RMAT designation includes the...